ASSESSING THE EFFECT OF COVID-19 ON TUBERCULOSIS TREATMENT OUTCOME IN ADAMAWA AND TARABA STATES, NORTH EASTERN NIGERIA
Abstract
Tuberculosis is a common, and in many cases lethal, infectious disease caused by various strains of mycobacteria. Successes in treatment of tuberculosis lead to reduction in transmission, complications, and mortality among patients. The outbreak of COVID-19 drew the attention of governments and healthcare practitioners. This study considers the effect of COVID-19 on Tuberculosis treatment. Data were sourced from Taraba and Adamawa States in North-east Nigeria. A total of 8820 patients’, records were used, with 3001 from Adamawa State and 5819 from Taraba State which involved TB patients’ records. At the bivariate level, the Pearson Chi-square test was employed to measure the association between the treatment outcome and the independent variables (local government area, treatment facility ownership, treatment regimen, patients’ supported, disease site, gender, HIV status and year of treatment). Thereafter multinomial Poisson regression analysis was performed on all statistically significant variables identified at the bivariate analysis. Decisions were taken based on p-value and odds ratios. The results of this study shows that the overall treatment success and cure rate across the States was on the average, 92.7% and 49.8% respectively. The highest treatment success rate of 94.5% was achieved in year 2021, while the year 2020 witnessed the highest cure rate of 53.5%. The overall cure rate of 49.8% is below the WHO recommendation. This study recommends that the non-pharmaceutical protocols to curtail the spread of COVID-19 should be strengthened in order to curtail TB spread, and that all TB patients should be tested for HIV.
References
Aggarwal, A. N., Agarwal, R., Dhooria, S., Prasad, K. T., Sehgal, I. S., and Muthu, V. (2022). Impact of COVID-19 pandemic on tuberculosis notifications in India. Lung India, 39(1) 89-91. Doi: 10.4103/lungindia.lungindia_604_21 DOI: https://doi.org/10.4103/lungindia.lungindia_604_21
Alagna, R., Besozzi, G., Codecasa, L. R., Gori, A., Migliori, G. B., Raviglione, M., and Cirillo, D. M. (2020). Celebrating World Tuberculosis Day at the time of COVID-19. European Respiratory Journal, 55(4) 1-3. DOI: https://doi.org/10.1183/13993003.00650-2020
Ahmed N. and Hasnain, S. (2011). "Molecular Epidemiology of Tuberculosis in India: Moving forward with a systems biology approach". Tuberculosis 91 (5): 407–413. DOI: https://doi.org/10.1016/j.tube.2011.03.006
Amiri, H., Mohammadi, M.J., Alavi, S.M., Salmannzadeh, S., Hematnia F., and Azar, M. (2021). Capture - recapture based study on the completeness of smear positive pulmonary tuberculosis reporting in southwest Iran during 2016. BMC Public Health 21, 2318 1-10. https://doi.org/10.1186/s12889-021-12398-w DOI: https://doi.org/10.1186/s12889-021-12398-w
Boffan, J., Mhlaba, T., Sulis, G., Moyo, S., Sifumba, Z., Pai, M., andDaftary, A. (2020). COVID-19 and tuberculosis in South Africa: A dangerous combination. SAMJ: South African medical journal, 110(5), 1-2. DOI: https://doi.org/10.7196/SAMJ.2020.v110i5.14747
Centres for Disease Control and Prevention (CDC, 2022). Effect of COVID-19 on Tuberculosis in the U.S. CDC online newsroom: Thursday, March 24, 2022.
Cilloni, L., Fu, H., Vesga, J. F., Dowdy, D., Pretorius, C., Ahmedov, S., Nair, S. A., Mosneaga, A., Masini, E., Sahu, S., and Arinaminpathy, N. (2020). The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine, 28, 100603. DOI: https://doi.org/10.1016/j.eclinm.2020.100603
Global Partnership for Zero Leprosy (GPZL, 2020). Working group assesses challenges and a path forward for leprosy during COVID-19. zeroleprosy.org
Madhukar, P., Tereza, K., and Soumya S. (2022). COVID-19’s Devastating Effect on Tuberculosis Care – A Path to Recovery. The new England journal of medicine; 386:1490-1493. doi: 10.1056/nejmp2118145 DOI: https://doi.org/10.1056/NEJMp2118145
Izudi, J.,Tamwesigire, I. K. and Bajunirwe, F. (2020). Treatment success and mortality among adults with tuberculosis in rural eastern Uganda: a retrospective cohort study. BMC Public Health (2020) 20:501 https://doi.org/10.1186/s12889-020-08646-0 DOI: https://doi.org/10.1186/s12889-020-08646-0
Jain, V. K., Iyengar, K. P., Samy, D. A., and Vaishya, R. (2020). Tuberculosis in the era of COVID-19 in India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 1439-1443. DOI: https://doi.org/10.1016/j.dsx.2020.07.034
John, S., Gidado, M., Dahiru, T., Fanning, A., Codlin, A. J., and Creswell, J. (2015). Tuberculosis among nomads in Adamawa, Nigeria: outcomes from two years of active case finding. The International Journal of Tuberculosis and Lung Disease, 19(4), 463-468. DOI: https://doi.org/10.5588/ijtld.14.0679
Kant, S. and Tyagi, R. (2021). The impact of COVID-19 on tuberculosis: challenges and opportunities. Therapeutic Advances in Infectious Diseases. doi: 10.1177/20499361211016973 DOI: https://doi.org/10.1177/20499361211016973
Liu, Q., Lu, P., Shen, Y., Li, C., Wang, J., Zhu, L., Lu. W., and Martinez, L. (2021). Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China. Clinical Infectious Diseases. 73(3) 542-544. https://doi.org/10.1093/cid/ciaa1289 DOI: https://doi.org/10.1093/cid/ciaa1289
Louie, J. K., Reid, M., Stella, J., Agraz-Lara, R., Graves, S., Chen, L. and Hopewell, P. (2020). A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic. Int J Tuberc Lung Dis, 24(8), 860-2. DOI: https://doi.org/10.5588/ijtld.20.0364
Nath, R., Gupta, N. K., Gupta, N., Tiwari, P., Kishore, J., and Ish, P. (2021). Effect of COVID-19 pandemic on tuberculosis notification. Indian J. Tuberc,doi: 10.1016/j.ijTb.2021.08.007 [Epub ahead of print]. Retrieved from https://www.ncbi.nih.gov/pmc/articles/PMC8358081/ on 6th June, 2022. DOI: https://doi.org/10.1016/j.ijtb.2021.08.007
National Tuberculosis Leprosy Control Programme (NTLCP, (n. d)). https://www.leprosy-information.org/organization/ntblcp-national-tuberculosis-leprosy-control-programme.
Oshi, D. C., Omeje, J. C., Oshi, S. N., Alobu, I. N., Chukwu, N. E., Nwokocha, C., Emelumadu, C. L., Meka, A. o. and Ukwaja, K. N. (2017). An evaluation of innovative community-based approaches and systematic tuberculosis screening to improve tuberculosis case detection in Ebonyi state, Nigeria. International journal of mycobacteriology, 6(3), 246-252. DOI: https://doi.org/10.4103/ijmy.ijmy_91_17
Soko, R. N., Burke, R. M., Feasey, H. R. A., Sibande, W., Nliwasa, M., Henrion, M. Y. R.,Khundi, M., Dodd, P. J., Ku, C. C., Kawalazira, G., Choko, A. T., Corbett, E. L., And MacPherson, P. (2021). Effects of Coronavirus Disease Pandemic on Tuberculosis Notification, Malawi. Emerging Infectious Diseases, 27(7), 1831-1839. Doi: 10.3201/eid2707.210557 DOI: https://doi.org/10.3201/eid2707.210557
Tadolini, M., García-García, J.-M., Blanc, F.-X., Borisov, S., Goletti, D., Motta, I., Codecasa, R, L., Tiberi, S., Sotgiu, G. and Migliori, G. B. (2020). On tuberculosis and COVID-19 co-infection. European Respiratory Journal, 56(2)2002328. DOI: https://doi.org/10.1183/13993003.02328-2020
Togun, T., Kampmann, B., Stoker, N. G. and Lipman, M. (2020). Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Annals of clinical microbiology and antimicrobials, 19, 1-6. DOI: https://doi.org/10.1186/s12941-020-00363-1
Udwadia, Z. F., Vora, A., Tripathi, A. R., Malu, K. N., Lange, C., and Raju, R. S. (2020). COVID-19-Tuberculosis interactions: When dark forces collide. Indian Journal of Tuberculosis. 67(4S):S155-S162. doi: 10.1016/j.ijtb.2020.07.003. DOI: https://doi.org/10.1016/j.ijtb.2020.07.003
Ukwaja, K. N., Alobu, I. and Hopewell, P. C. (2013). The high cost of free tuberculosis services: patient and household costs associated with tuberculosis care in Ebonyi State, Nigeria. PloS one, 8(8), e73134. DOI: https://doi.org/10.1371/journal.pone.0073134
Ungvarski, P. J., and Flaskerud, J. H. (1999). HIV/AIDS: A guide to primary care management: Philadelphia: WB Saunders
Visca, D., Ong, C. W. M., Tiberi, S., Centis, R., D’Ambrosio, L., Chen, B., Mueller J., Duarte, R., Dalcolmo, M., Sotgiu. G., Migliori G.B. and Goletti, D. (2021). Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology. 27(2):151-165. doi: 10.1016/j.pulmoe.2020.12.012. DOI: https://doi.org/10.1016/j.pulmoe.2020.12.012
World Health Organization (2003). Treatment of tuberculosis: guidelines for national programmes. Geneva
World Health Organization Regional Office for Africa (2017). Framework for implementing the End TB in African Region 2016-2020https://apps.who.int/iris/bitstream/handle/10665/259636/TBstrat-eng.pdf?sequence=1#:~:text=It%20aims%20to%20end%20the,the%20TB%20epidemic%20by%202030.
World Health Organization (2021a). WHO consolidated guidelines on tuberculosis Module 2: Screening – Systematic screening for tuberculosis disease. https://www.who.int/publications/i/item/9789240022676
World Health Organization (2021b). Global tuberculosis report: TB Mortality. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021/disease-burden/mortality
Copyright (c) 2023 FUDMA JOURNAL OF SCIENCES
This work is licensed under a Creative Commons Attribution 4.0 International License.
FUDMA Journal of Sciences
